Officials lift pause on Johnson & Johnson COVID-19 vaccine
Federal officials said that the United States should resume use of the Johnson & Johnson COVID-19 vaccine, which has been on pause since April 13th. The company updated the fact sheets about the vaccine for doctors and patients to include information about the risks of clots.
Vaccinations with the Johnson & Johnson shot could start back up as soon as tomorrow morning, said Peter Marks, director of the FDA’s Center for Biologics Evaluation and Research, during a press briefing.
The decision to reinstate the J&J vaccine follows the recommendation of an independent CDC advisory group earlier today. The committee stressed that officials should make people aware of the risk of rare blood clots, which appear most often in women under 50.